| Researchers report a materials breakthrough enabling a new wave of nanodrug applications, from delivery to diagnostics and gene editing, with global impact.
(Nanowerk News) An Australian research team has achieved an advanced materials breakthrough that opens the door to a new generation of nanodrug applications. From drug delivery, to diagnostics, to gene editing and beyond, the breakthrough has the potential to improve outcomes for patients around the world in coming decades. |
| Using the Australian Synchrotron and state-of-the-art cryo-imaging, the team has developed a new class of lipid nanoparticles (LNPs) that form complex internal arrangements such as cubes or hexagons. These “nonlamellar” (cubes/hexagons) structures significantly expand the potential of LNPs by providing more surface area and greater versatility for carrying a wide variety of cargo, including small-molecule drugs, proteins, metal ions and mRNA. |
| LNPs are best known as the delivery vehicles that enabled the Pfizer–BioNTech and Moderna COVID-19 vaccines, protecting fragile mRNA molecules and ensuring they reach target cells. Their success during the pandemic sparked global investment in RNA medicines, which are now being explored for cancer treatment, immunotherapy and genetic disorders. |
| The study, published in the journal Advanced Materials (“Polyphenol‐Mediated Engineering of Lipid Nanoparticles With Crystalline Mesophases”), was co-led by University of Melbourne Laureate Professor Frank Caruso, Head of the Caruso Nanoengineering Group, and Dr Yi (David) Ju, Head of the Nanomedicine and Gene Therapeutics Laboratory at the Olivia Newton-John Cancer Research Institute (ONJCRI) and La Trobe University, together with colleagues from RMIT University. |
| “A key benefit of our new class of LNPs is that their nonlamellar structures are tuneable – meaning their internal order and size can be precisely adjusted by varying the formulation. This flexibility allows us to design delivery systems for different classes of therapeutic molecules,” said first author of the study Dr Shiyao Li, who is a Postdoctoral Researcher at ONJCRI. |
| “This new class has been created from polyphenols – naturally occurring plant compounds with antioxidant and anti-inflammatory properties – in combination with a lipid,” Professor Caruso said. |
| “The breakthrough will bring insights into nanostructured materials design and allow new applications in diverse fields, from molecular delivery for cancer treatments, to protein and gene therapies, and even diagnostic nanomaterials. There is wide capacity to tailor these materials to different delivery needs.” |
| Dr Ju said the team has patented a library of this new class of LNPs and that “the team is very excited about the potential of this new platform technology and is looking for industry partners to work with to develop new mRNA therapeutics”. |
| “Within five years, we hope to validate the platform with new therapeutic applications in animal models. Importantly, these LNPs can be produced using the same assembling equipment as current vaccines, but with components that are significantly more affordable than those found in existing LNP drug delivery formulations,” he said. |
| Source: University of Melbourne (Note: Content may be edited for style and length) |
News
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
